EPCLUSA (Velpatasvir & sofosbuvir)

(EPCLUSA is registered trademarks Gilead Sciences Inc.)

 

What is EPCLUSA:

EPCLUSA is a medicine that contains the active substance Velpatasvir & Sofosbuvir and is available as tablets.

 

About Medicine

Name: EPCLUSA
Generic Name: Velpatasvir & sofosbuvir
Strength: 400 mg of sofosbuvir and 100 mg of velpatasvir
Company: Gilead Sciences Inc.
Packing: 28 tablets in one bottle

 

In how many countries EPCLUSA is approved for marketing?

EPCLUSA is available/approved in USA and Europe. We can help you to access it in India.

 

What is EPCLUSA used for?

EPCLUSA is indicated for the treatment of adult patients with chronic HCV genotype 1, 2, 3, 4, 5 or 6 infection:
• without cirrhosis or with compensated cirrhosis
• with decompensated cirrhosis for use in combination with ribavirin

 

How can I get EPCLUSA in India?

EPCLUSA is a prescription only drug and is not approved for marketing in India.

The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at –info@theindianpharma.com

We facilitate by –

• Helping in documentation to import the medicine for personal use

• Finding Genuine and reliable source in USA, Europe and Japan

• Ensuring 100% transparency.

EPCLUSA can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.

The Indian Pharma can facilitate the supply of EPCLUSA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.

The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees

 

Can I get EPCLUSA even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country
The Indian Pharma (IP) can help patients in accessing/importing EPCLUSA, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your enquiry to find –

EPCLUSA in South East Asia – China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.

EPCLUSA in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.

EPCLUSA in North America – Mexico.

EPCLUSA in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.

EPCLUSA in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.

EPCLUSA in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.

EPCLUSA in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.

EPCLUSA in Australia and New Zealand.

 

How is EPCLUSA used?

EPCLUSA should be administered under the guidance of specialist doctor having experience in managing cancer treatments.
Recommended dose: One tablet (400 mg of sofosbuvir and 100 mg of velpatasvir) taken orally once daily with or without food.
If the patient develops certain serious side effects then doctor may interrupt or stop treatment, or reduce the dose. See the summary of product characteristics on company official website for more information

 

Are there any side-effects/ adverse reactions/precautions associated with treatment with EPCLUSA?

It is recommended to seek your doctor’s medical advice about side effects

 

How do I contact The Indian Pharma?

You can use different channel to contact The Indian Pharma (IP)
Tele & Mobile: You can reach us on +91 8826990915 or +91-120-4080562 on any working days.
Email: We can also address your enquiries if sent directly to info@theindianpharma.com. We will respond within 24 hours after receiving your mail. Please mention detailed enquiry, your contact number with ISD code while sending your mail. We will respond within 1 working days after receiving your query form.

 

What information do you need to help patient in assisting documentation for EPCLUSA import for personal use?

We will require the following documents to help in documentation for Named-Patient import

  • Doctor’s Prescription – We would require prescription from Registered Medical Practitioner Stating Product name, dosage, duration of treatment and diagnosis
  • Patient’s Medical history – We would require all test reports and Medical reports of the patient for last 3 months.
  • Patient’s Identity card – We will require scan copy of Patient’s identity card and proof of residence to initiate documentation process. You can use copy of Passport, Driving License, Employee ID card or any Photo ID document as your Identity card.

Contact Details

The Indian Pharma
905, I - Thum Business Park,
Plot No. A-40, Unit No. 5, Tower A,
Sector-62, Noida – 201301 (India)

Phone No.- +91-120-4080562.
M: +91 9650877511

WhatsApp: +91 9650877511
QQID:- 1927411523
Skype ID: tuhinsharma

E: info@theindianpharma.com